Hyundai Bioscience
048410.KQ
10.21 USD
0.08
+0.79%
h
Overview
Last close
10.21 usd
Market cap
490.31M usd
52 week high
16.53 usd
52 week low
6.33 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
64.0316
Price/Book Value
5.6871
Enterprise Value
443.60M usd
EV/Revenue
57.2015
EV/EBITDA
-64.6317
Key financials
Revenue TTM
7.76M usd
Gross Profit TTM
6.65M usd
EBITDA TTM
-2.85M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
96.62M usd
Net debt
N/A usd
About
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
- Symbol048410.KQ
- ExchangeKQ
- IsinKR7048410005
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEOJong-Won Choi
- HeadquarterSeoul
- Web sitehttps://www.hyundaibioscience.com
Related indices
Related news
December 13
JAKOTA Stocks on December 13, 2023 November 3
JAKOTA Stocks on November 3, 2023 